Hyperoxia during cardiopulmonary bypass does not decrease cardiovascular complications following cardiac surgery: the CARDIOX randomized clinical trial

Osama Abou‐Arab(Centre Hospitalier Universitaire Amiens-Picardie), Pierre‐Grégoire Guinot(Université de Picardie Jules Verne), Gilles Touati(Centre Hospitalier Universitaire Amiens-Picardie), Estelle Josse(Centre Hospitalier Universitaire Amiens-Picardie), Bélaïd Bouhemad(Hôpital Paris Saint-Joseph), Pierre Huette(Centre Hospitalier Universitaire Amiens-Picardie), Christophe Beyls(Centre Hospitalier Universitaire Amiens-Picardie), Clémence Beauvalot(CHU Dijon Bourgogne), Lucie Martineau(Centre Hospitalier Universitaire Amiens-Picardie), Emmanuel Lorne(Inserm), Olivier Bouchot(Hospices Civils de Lyon), Momar Diouf(Centre Hospitalier Universitaire Amiens-Picardie)
Intensive Care Medicine
October 1, 2019
10.1007/s00134-019-05761-4
Cited by 49

Related Papers

International evidence-based recommendations for point-of-care lung ultrasound
|Intensive Care Medicine|2012|2.9k
Quantitative Lung Ultrasound: Technical Aspects and Clinical Applications
|Anesthesiology|2021|260
Immunocyt Test Improves the Diagnostic Accuracy of Urinary Cytology: Results of a French Multicenter Study
|The Journal of Urology|2003|138
Postoperative Pulmonary Complications After Cardiac Surgery: The VENICE International Cohort Study
|Journal of Cardiothoracic and Vascular Anesthesia|2021|88
Monitoring dynamic arterial elastance as a means of decreasing the duration of norepinephrine treatment in vasoplegic syndrome following cardiac surgery: a prospective, randomized trial
|Intensive Care Medicine|2017|75